Patrys Limited PAB.AX Stock
Patrys Limited Price Chart
Patrys Limited PAB.AX Financial and Trading Overview
| Patrys Limited stock price | 0.0100 AUD |
| Previous Close | 0.01 AUD |
| Open | 0.01 AUD |
| Bid | 0.01 AUD x 0 |
| Ask | 0.01 AUD x 0 |
| Day's Range | 0.01 - 0.01 AUD |
| 52 Week Range | 0.01 - 0.03 AUD |
| Volume | 2.67M AUD |
| Avg. Volume | 2.96M AUD |
| Market Cap | 20.57M AUD |
| Beta (5Y Monthly) | 0.293486 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PAB.AX Valuation Measures
| Enterprise Value | 16.77M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.8701973 |
| Price/Book (mrq) | 2 |
| Enterprise Value/Revenue | 4.786 |
| Enterprise Value/EBITDA | -2.744 |
Trading Information
Patrys Limited Stock Price History
| Beta (5Y Monthly) | 0.293486 |
| 52-Week Change | -47.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.03 AUD |
| 52 Week Low | 0.01 AUD |
| 50-Day Moving Average | 0.01 AUD |
| 200-Day Moving Average | 0.02 AUD |
PAB.AX Share Statistics
| Avg. Volume (3 month) | 2.96M AUD |
| Avg. Daily Volume (10-Days) | 1.38M AUD |
| Shares Outstanding | 2.06B |
| Float | 1.45B |
| Short Ratio | N/A |
| % Held by Insiders | 30.26% |
| % Held by Institutions | 10.56% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -175.76% |
| Operating Margin (ttm) | -175.76% |
| Gross Margin | 100.00% |
| EBITDA Margin | -174.42% |
Management Effectiveness
| Return on Assets (ttm) | -25.16% |
| Return on Equity (ttm) | -48.91% |
Income Statement
| Revenue (ttm) | 3.5M AUD |
| Revenue Per Share (ttm) | 0.002 AUD |
| Quarterly Revenue Growth (yoy) | 10.29% |
| Gross Profit (ttm) | 3.33M AUD |
| EBITDA | -6112974 AUD |
| Net Income Avi to Common (ttm) | -6160017 AUD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.84M AUD |
| Total Cash Per Share (mrq) | 0.003 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.515 |
| Book Value Per Share (mrq) | 0.005 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6913922 AUD |
| Levered Free Cash Flow (ttm) | -7534735 AUD |
Profile of Patrys Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 100 Albert Road |
| ZIP | 3205 |
| Phone | 61 3 9670 3273 |
| Website | https://www.patrys.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. The company was incorporated in 2006 and is based in Melbourne, Australia.
Q&A For Patrys Limited Stock
What is a current PAB.AX stock price?
Patrys Limited PAB.AX stock price today per share is 0.0100 AUD.
How to purchase Patrys Limited stock?
You can buy PAB.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Patrys Limited?
The stock symbol or ticker of Patrys Limited is PAB.AX.
Which industry does the Patrys Limited company belong to?
The Patrys Limited industry is Biotechnology.
How many shares does Patrys Limited have in circulation?
The max supply of Patrys Limited shares is 2.06B.
What is Patrys Limited Price to Earnings Ratio (PE Ratio)?
Patrys Limited PE Ratio is now.
What was Patrys Limited earnings per share over the trailing 12 months (TTM)?
Patrys Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Patrys Limited company belong to?
The Patrys Limited sector is Healthcare.